Pages that link to "Q34169118"
Jump to navigation
Jump to search
The following pages link to Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. (Q34169118):
Displaying 50 items.
- Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins (Q24303447) (← links)
- Cloning, expression, and chromosomal assignment of the human mitochondrial intermediate peptidase gene (MIPEP) (Q24309574) (← links)
- Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers (Q24671334) (← links)
- Study of a single BRCA2 mutation with high carrier frequency in a small population (Q24680535) (← links)
- Genomic alterations in pancreatic cancer and their relevance to therapy (Q26781443) (← links)
- Representational difference analysis using minute quantities of DNA (Q27473246) (← links)
- Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis? (Q28066454) (← links)
- DOCK4, a GTPase activator, is disrupted during tumorigenesis (Q28182054) (← links)
- Identification of the breast cancer susceptibility gene BRCA2 (Q29616290) (← links)
- A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers (Q30434796) (← links)
- Knowledge discovery in gene-expression-microarray data: mining the information output of the genome (Q30582293) (← links)
- Molecular technology and pancreatic cancer (Q31800438) (← links)
- A high-resolution annotated physical map of the human chromosome 13q12-13 region containing the breast cancer susceptibility locus BRCA2. (Q33571596) (← links)
- Pancreatic adenocarcinoma: epidemiology and genetics (Q33677968) (← links)
- BRCA-associated cancer risk: molecular biology and clinical practice (Q33685110) (← links)
- Screening and clinical implications for BRCA1 and BRCA2 mutation carriers (Q33923799) (← links)
- Molecular genetic alterations in ductal pancreatic adenocarcinomas (Q33953503) (← links)
- Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis (Q34152841) (← links)
- Low incidence of BRCA2 mutations in breast carcinoma and other cancers (Q34381064) (← links)
- A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes (Q34385903) (← links)
- Molecular genetics of ovarian cancer (Q34430073) (← links)
- Cancer risks in BRCA2 mutation carriers (Q34504452) (← links)
- Molecular Characteristics of Pancreatic Ductal Adenocarcinoma (Q34745252) (← links)
- Isolation of YAC insert sequences by representational difference analysis (Q34776893) (← links)
- Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer (Q35238455) (← links)
- Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer (Q35594607) (← links)
- The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma. (Q35764659) (← links)
- Molecular biology of exocrine pancreatic cancer. (Q36499575) (← links)
- Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias (Q36591365) (← links)
- Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis (Q36623649) (← links)
- Amplification of EMSY gene in a subset of sporadic pancreatic adenocarcinomas (Q36784879) (← links)
- Alu-polymerase chain reaction genomic fingerprinting technique identifies multiple genetic loci associated with pancreatic tumourigenesis (Q36841881) (← links)
- Pancreatic carcinogenesis (Q37125627) (← links)
- Pancreatic cancer: BRCA mutation and personalized treatment (Q38592167) (← links)
- The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development (Q38745817) (← links)
- Gene-expression profiling to predict responsiveness to immunotherapy (Q39005203) (← links)
- The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer (Q39080898) (← links)
- Digital karyotyping: an update of its applications in cancer (Q39764282) (← links)
- Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX. (Q40013277) (← links)
- Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines (Q40791054) (← links)
- Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36. (Q40795397) (← links)
- Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancer. (Q40837209) (← links)
- The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis (Q40855140) (← links)
- Prostate Cancer Susceptibility Locus on Chromosome 1q: a Confirmatory Study (Q40887103) (← links)
- High-density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p. (Q40979749) (← links)
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds (Q41226231) (← links)
- Tumour-suppressor genes in prostatic oncogenesis: a positional approach (Q41409406) (← links)
- Molecular diagnosis of pancreas carcinoma (Q41528285) (← links)
- Genetics of pancreatic cancer. From genes to families. (Q41690568) (← links)
- Role of Growth Factors in Pancreatic Cancer (Q41690572) (← links)